{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9568181", "DateCompleted": {"Year": "1998", "Month": "05", "Day": "13"}, "DateRevised": {"Year": "2007", "Month": "11", "Day": "15"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0250-7005", "JournalIssue": {"Volume": "18", "Issue": "1B", "PubDate": {"Year": "1998", "Season": "Jan-Feb"}}, "Title": "Anticancer research", "ISOAbbreviation": "Anticancer Res"}, "ArticleTitle": "Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract.", "Pagination": {"StartPage": "583", "EndPage": "586", "MedlinePgn": "583-6"}, "Abstract": {"AbstractText": ["A prospectively randomized clinical study was performed with breast carcinoma patients to determine the correlation of defined parameters of the cellular immunity and beta-endorphin plasma levels after mistletoe lectin (ML-1) standardized therapy. The subcutaneous administration of optimal ML-1 dosages (0.5-1.0 ng ML-1/kg body weight; twice a week) induced an increased beta-endorphin plasma level, enhanced activity of peripheral blood natural killer (NK-)cells and T-lymphocytes (expression of CD-25/interleukin-2 receptors and HLA/DR-antigens). Statistical analysis of the data (Spearman correlation) revealed a significant correlation between NK- and T-cell activity and beta-endorphin plasma level. Thus, an obvious correlation between immune system and the neuroendocrine system may be anticipated which might gain therapeutical relevance."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medical Microbiology und Hygiene, University of Cologne, Germany."}], "LastName": "Heiny", "ForeName": "B M", "Initials": "BM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Albrecht", "ForeName": "V", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Beuth", "ForeName": "J", "Initials": "J"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Anticancer Res", "NlmUniqueID": "8102988", "ISSNLinking": "0250-7005"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ribosome Inactivating Proteins, Type 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Toxins, Biological"}, {"RegistryNumber": "0", "NameOfSubstance": "ribosome inactivating protein, Viscum"}, {"RegistryNumber": "60617-12-1", "NameOfSubstance": "beta-Endorphin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood", "immunology", "therapy"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunity, Cellular"}, {"QualifierName": ["immunology"], "DescriptorName": "Killer Cells, Natural"}, {"QualifierName": [], "DescriptorName": "Mistletoe"}, {"QualifierName": [], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plant Proteins"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Ribosome Inactivating Proteins, Type 2"}, {"QualifierName": ["immunology"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Toxins, Biological"}, {"QualifierName": ["blood"], "DescriptorName": "beta-Endorphin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "5", "Day": "6"}, {"Year": "1998", "Month": "5", "Day": "6", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "5", "Day": "6", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9568181"]}}]}